Keizaburo Ogawa

Title: Keizaburo Ogawa: Innovator in Pharmaceutical Technology

Introduction

Keizaburo Ogawa is a notable inventor based in Kawagoe, Japan. He has made significant contributions to the field of pharmaceutical technology, particularly in the development of sustained release formulations. With a total of 2 patents to his name, Ogawa's work has the potential to enhance the efficacy of medications.

Latest Patents

Ogawa's latest patents include a sustained release pharmaceutical tablet of theophylline and a theophylline sustained release granule. The sustained release pharmaceutical tablet comprises theophylline and ethyl cellulose uniformly dispersed in a specific ratio. This formulation allows for a controlled release of theophylline, which is crucial for maintaining therapeutic levels in the bloodstream. The second patent, the theophylline sustained release granule, consists of a combination of theophylline, a metal salt of higher fatty acid, and ethyl cellulose. This granule formulation is designed to maintain a suitable concentration of theophylline in the blood over an extended period.

Career Highlights

Keizaburo Ogawa is associated with Nikken Chemicals Co., Ltd., where he has been instrumental in advancing pharmaceutical formulations. His innovative approaches have contributed to the company's reputation in the industry.

Collaborations

Ogawa has collaborated with notable colleagues such as Tadashi Ukigaya and Satoru Tanaka. Their combined expertise has fostered a productive environment for research and development in pharmaceutical technologies.

Conclusion

Keizaburo Ogawa's contributions to sustained release pharmaceutical formulations demonstrate his commitment to improving medication delivery systems. His patents reflect a deep understanding of pharmaceutical science and a dedication to enhancing patient care.